{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:08:24Z","timestamp":1790791704459,"version":"4.1.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Marie Sklodowska-Curie Innovative Training Networks","award":["643130"],"award-info":[{"award-number":["643130"]}]},{"name":"Marie Sklodowska-Curie Innovative Training Networks","award":["643130"],"award-info":[{"award-number":["643130"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1080\/2162402x.2020.1761229","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:40:30Z","timestamp":1590140430000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition"],"prefix":"10.1080","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-3666","authenticated-orcid":false,"given":"Victor","family":"Cervera-Carrascon","sequence":"first","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"TILT Biotherapeutics Ltd","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne C.A.","family":"Quixabeira","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao Manuel","family":"Santos","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"TILT Biotherapeutics Ltd","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"Havunen","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"TILT Biotherapeutics Ltd","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Zafar","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Hemminki","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"Helsinki University Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Heini\u00f6","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Munaro","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Siurala","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"TILT Biotherapeutics Ltd","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Sorsa","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"TILT Biotherapeutics Ltd","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0455-9891","authenticated-orcid":false,"given":"Tuomas","family":"Mirtti","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"Helsinki University Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-4609","authenticated-orcid":false,"given":"Petrus","family":"J\u00e4rvinen","sequence":"additional","affiliation":[{"name":"Helsinki University Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mildh","sequence":"additional","affiliation":[{"name":"Helsinki University Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Nisen","sequence":"additional","affiliation":[{"name":"Helsinki University Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4261-3484","authenticated-orcid":false,"given":"Antti","family":"Rannikko","sequence":"additional","affiliation":[{"name":"Helsinki University Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjukka","family":"Anttila","sequence":"additional","affiliation":[{"name":"Finnish Food Safety Authority (EVIRA)","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kanerva","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"Helsinki University Central Hospital","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[{"name":"University of Helsinki","place":["Helsinki, Finland"]},{"name":"TILT Biotherapeutics Ltd","place":["Helsinki, Finland"]},{"name":"Helsinki University Hospital Comprehensive Cancer Center","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0476"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0053-3"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/284581"},{"key":"e_1_3_4_5_1","first-page":"61","article-title":"Immunotherapy of melanoma","volume":"22","author":"Lugowska I","year":"2018","unstructured":"Lugowska I, Teterycz P, Rutkowski P. Immunotherapy of melanoma. Contemp Oncol. 2018;22:61\u201367.","journal-title":"Contemp Oncol"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1145652"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.88"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.15_suppl.3001"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00587-0"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00608-2"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13027"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1074377"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0014-6"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.06.001"},{"key":"e_1_3_4_20_1","first-page":"3(7):e99573","article-title":"Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses","author":"Watanabe K","year":"2018","unstructured":"Watanabe K, Luo Y, Da T, Guedan S, Ruella M, Scholler J, Keith B, Young RM, Engels B, Sorsa S, et al. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 2018;3(7):e99573.","journal-title":"JCI Insight"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1412902"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2016.12.004"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131242"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.137"},{"key":"e_1_3_4_25_1","first-page":"8:e000188","article-title":"Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity","author":"Santos JM","year":"2020","unstructured":"Santos JM, Heinio C, Cervera-Carrascon V, Quixabeira DCA, Siurala M, Havunen R, Butzow R, Zafar S, de Gruijl T, Lassus H, et al. Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity. J Immunother Cancer. 2020;8:e000188.","journal-title":"J Immunother Cancer"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30839"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010192"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30723-8"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.172"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.065"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1348"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0948"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.026"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196464"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3271"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802166115"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98047"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.08.004"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/OV.S145532"},{"key":"e_1_3_4_40_1","article-title":"Trial watch: oncolytic viro-immunotherapy of hematologic and solid tumors","author":"G. Pol J","year":"2018","unstructured":"G. Pol J,L\u00e9vesque S, Workenhe ST, Gujar S, Le Boeuf F, R. Clements D, Fahrner J-E, Fend L, C Bell J, L. Mossman K, Fucikova J, Spisek R, et al. Trial watch: oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 2018;;7:e1503032.","journal-title":"Oncoimmunology"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.027"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0216"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(89)90026-9"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1136046"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2020.1761229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:01:34Z","timestamp":1756998094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2020.1761229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1080\/2162402X.2020.1761229"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2020.1761229","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1761229"}}